Williams Kherkher selected among America’s 25 most influential law firms

Williams Kherkher is proud to be included in the list of the America’s 25 most influential law firms for 2016.

This list is compiled by The National Trial Lawyers and was announced in the organization’s magazine, The Trial Lawyer. Members of this list are referred to as “The Forum.” Members of The Forum are nominated by the magazine’s readers. These firms have each demonstrated an ability to make an impact on the practice of law, and have shown leadership, innovation, and success.

Members of The Forum have been invited to a special awards luncheon in South Beach, Miami, on February 6th.

Click here to see the full list.


Former US fentanyl-maker employees arrested

Last month, at six former officials of pharmaceutical company Insys Therapeutics were arrested for allegedly bribing doctors.

According to the court documents, the indicted employees reportedly operated a kickback scheme that motivated doctors to prescribe company’s highly addictive fentanyl product, Subsys. The six ex-employees, including the company’s former CEO, were charged with conspiracy to commit racketeering and wire and mail fraud, and conspiracy to violate the Anti-Kickback Statute.

Initial reports say that the kickback scheme took place sometime between June 2012 and December 2015. Since then, due to company’s aggressive marketing strategies and alleged bribing kickback scheme, the company successfully captured half of the rapid-acting fentanyl products market.

Fentanyl is an FDA-approved synthetic opioid use to manage pain in cancer patients. It is fast acting and 50 to 100 times more powerful than morphine.

If you or someone you love suffered an addiction caused by a fentanyl spray, we might be able to help you. Our lawyers at Williams Kherkher are experienced in litigating pharmaceutical cases and can help you throughout the process. Get in touch with us at (888) 220-0640 to learn more about your legal options.


Impact of FDA power morcellation warning

In 2014, the US Food and Drug Administration (FDA) issued a warning about the potential risks of using laparoscopic power morcellators in hysterectomies or myomectomies. Since the announcement, there was a decrease in the utilization of minimally invasive hysterectomies, based on a retrospective cohort study conducted by the faculty from the University of Michigan Department of Obstetrics and Gynecology.

In the review, the utilization of power morcellators has significantly decreased, but cases in which a practitioner still opts to use major surgical non-transfusion, complications have increased by 27 percent and occurrences of 30-day hospital re-admissions have increased by 25 percent. Although the cause of the shift in practice patterns has yet to be determined, the study suggests that it has something to do with the FDA announcement discouraging the use of the medical device.

If you or someone you know has developed an undetected cancer following a hysterectomy or myomectomy involving a power morcellator, you may be entitled to a financial compensation. Our lawyers at Williams Kherkher have worked closely with these lawsuits and can properly represent you in court. Get in touch with us at (888) 220-0640 to learn more about your legal options.


FDA identifies hospitals non-compliant with medical device reporting standards

At least fifteen hospitals across the United States failed to comply with the medical device reporting requirements, according to the FDA.

The FDA issued a Form FDA 483 to some prominent hospitals, including Massachusetts General Hospital and New York Presbyterian Hospital, for not promptly reporting deaths and injuries related to medical devices pursuant to 21 CFR Part 803. Under the federal regulation, user facilities, such as hospitals and health centers, have only ten days to submit reports about deaths of patients and serious injuries linked to medical devices to its manufacturer and the FDA. The rule also states that a user facility should maintain a medical device event filing system, which can be inspected by FDA. Out of 17 hospitals, 15 medical centers reportedly demonstrated failures to comply with the federal rule following FDA nationwide inspections. The inspection was initiated last December 2015.

If you or your loved one has been physically injured due to an accident involving a power morcellator, you may be entitled to a monetary claim. Our lawyers at Williams Kherkher have the experience and skills to properly represent you in court. Get in touch with us at (888) 220-0640.


Three things you should know about morcellation

A power morcellator is an electronic surgical device that has been used by doctors to minimize how invasive several abdominal procedures can be. However, in 2014, the usage of the device was put under criticism following the announcement of the US Food and Drug Administration (FDA) against the device, citing evidence that morcellators could spread cancer cells throughout a patient’s body. Here are some things you need to know about the device:

  1. Morcellators had been introduced to the public 20 years ago – The US Government Accountability Office (GOA) is investigating the case to determine why FDA cleared morcellators for use despite its potential risks.
  2. Risks of using morcellators are often overlooked – A recent study in South Korea shows that morcellating tumors is more dangerous than removing them with more invasive measures, as this is more likely to spread cancer.
  3. Warning led to changes in surgeries – After the morcellator issue had been spilled into the public sphere, US gynecologists changed the way they perform hysterectomies, preferring other options with fewer complications.

If you have developed cancer following a procedure involving a power morcellator, we might be able to help you. Contact our lawyers from Williams Kherkher at (888) 220-0640.


SEO for Lawyers